Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab bronchoscopy study in uncontrolled asthma
2014-000275-14Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Lebrikizumab with Placebo (2 arms). Primary endpoint: Relative change in number of airway submucosal eosinophils per surface area of basal lamina. Started Jun 2014; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-000275-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000275-14.